午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Biotin-PEG4-SS-Alkyne

Biotin-PEG4-SS-Alkyne Struktur
1260247-54-8
CAS-Nr.
1260247-54-8
Englisch Name:
Biotin-PEG4-SS-Alkyne
Synonyma:
Biotin-PEG4-SS-Alkyne;12,15,18,21-Tetraoxa-4,5-dithia-8,24-diazanonacosanamide, 29-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-9,25-dioxo-N-2-propyn-1-yl-
CBNumber:
CB95477857
Summenformel:
C29H49N5O8S3
Molgewicht:
691.92
MOL-Datei:
1260247-54-8.mol

Biotin-PEG4-SS-Alkyne Eigenschaften

Siedepunkt:
990.6±65.0 °C(Predicted)
Dichte
1?+-.0.06 g/cm3(Predicted)
pka
13.90±0.40(Predicted)

Sicherheit

Biotin-PEG4-SS-Alkyne Chemische Eigenschaften,Einsatz,Produktion Methoden

Biotin-PEG4-SS-Alkyne Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Biotin-PEG4-SS-Alkyne Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 9)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Alfa Chemistry
+1-5166625404;
Info@alfa-chemistry.com United States 20405 58
Hangzhou MolCore BioPharmatech Co.,Ltd.
+86-057181025280; +8617767106207
sales@molcore.com China 49734 58
Xian confluore Biological Technology Co., Ltd.
+86-15680926068
1924344760@confluore.cn China 2997 58
Xi'an Confluore Biological Technology Co., Ltd. +86-156-80926068 +86-15680926068
1924344760@qq.com China 4841 58
Zhengzhou Acme Chemical Co., Ltd. 0371-037163312495,13303845143 13303845143
3001379618@qq.com China 10321 58
Hangzhou Taorui Biotechnology Co., Ltd 4000-360-990 15268198094
sales@torreybio.com China 3507 58
Affinity(Wuhan)Ltd. 15841022315
sales@affinitytech.cn China 2999 58
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd. 025-025-66113011 18626450290
cb5@aikonchem.com China 10359 58
TargetMol Chemicals Inc. 15002134094
marketing@targetmol.cn China 25573 58

  • 12,15,18,21-Tetraoxa-4,5-dithia-8,24-diazanonacosanamide, 29-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-9,25-dioxo-N-2-propyn-1-yl-
  • Biotin-PEG4-SS-Alkyne
  • 1260247-54-8
  • C29H49N5O8S3
Copyright 2019 ? ChemicalBook. All rights reserved